During the first semester of the business year 2017/18 we achieved a consolidated total turnover of CHF 213.4 million. The growth represents an increase in sales of 15.1 % (previous year: CHF 185.4 million). The operating result (EBIT) amounts to CHF 26.9 million (previous year: CHF 28.1 million) with an EBIT margin of 12.6 %. The first halfyear is impacted by the costs of the launch activities and amortisations for our new mylife™ YpsoPump® insulin pump to the extent of CHF 7.5 million. The net profit in the first half-year amounted to CHF 23.4 million (previous year: CHF 22.4 million). The increase in net profits was influenced by positive currency exchange rates and lower tax burdens amongst other things.
Download annual and semiannual reports
On this page you can download all financial publications of Ypsomed Holding AG covering the last ten years of business activity. If you prefer a printed copy, please use the order form on this page.